CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 40 enrolled
Drug / intervention
Proton Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01839838
NCT01839838Phase 2Completed
CompareCT.gov

A Feasibility And Phase Ii Trial Of Accelerated Partial Breast Irradiation Using Proton Therapy For Women With Stage IA-IIA Breast Cancer

Abramson Cancer Center at Penn Medicine·interventional·Posted Apr 25, 2013·Updated Nov 7, 2024

In Brief

A Phase 2 clinical trial evaluating Proton Therapy for Stage IA-IIA Breast Cancer. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The overall objectives of the study are to establish feasibility and acute side effects of accelerated partial breast irradiation therapy, along with more long-term side effects and clinical efficacy of treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStage IA-IIA Breast Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 25, 2013
Enrollment StartApr 22, 2013
Primary CompletionDec 23, 2022
TodayJul 2, 2026
Enrollment to primary: 9.7 yearsPosted 13.2 years ago

Interventions

Proton Therapyradiation